Technology | 2016.05.06
Gene Editing Company Intellia Therapeutics Prices Their IPO At $18.00, The Top Of The Range - Seeking Alpha
| FierceBiotech | Gene Editing Company Intellia Therapeutics Prices Their IPO At $18.00, The Top Of The Range Seeking Alpha The proceeds of the offering will be used to advance the research and development, progress additional product candidates, further develop their delivery technologies and CRISPR/Cas9 gene editing platform and for working capital and other general ... Gene editing firm Intellia raises $163M in largest biotech IPO of 2016 Bullish Intellia Therapeutics raises $108M in top range IPO CRISPR Drug Maker Intellia Therapeutics Sells $108M In IPO Shares |
For more information, please visit
http://news.google.com/news/url?sa=t&fd=[...]ng-company-intellia-therapeuti
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1530
Here’s a ‘Brand-New’ Massive Multilingual Dataset for Machine Translation views: 1527